Literature DB >> 19809890

Prokaryotic expression and characterization of avian influenza A virus M2 gene as a candidate for universal recombinant vaccine against influenza A subtypes; specially H5N1 and H9N2.

Seyyed Mahmoud Ebrahimi1, Majid Tebianian, Khosrow Aghaiypour, Hassan Nili, Ali Mirjalili.   

Abstract

The conserved M2 protein of influenza A virus is considered as a promising candidate target for a broad-spectrum, recombinant influenza A vaccine. In the present study, the open reading frame (ORF) of avian influenza A/chicken/Iran/101/1998 (H9N2) M2 gene was amplified then cloned in pAED4, prokaryotic expression vector. M2 protein was produced through the expression of this recombinant expression vector (pAED4-M2) in E. coli BL21 (DE3) strain. The expressed M2 protein was analyzed on SDS-PAGE. Western blot assay was used to examine the immunoreaction of the expressed protein using commercial polyclonal anti-M2 antibody. The antigenicity and biological activity of the recombinant protein was also qualitatively detected on infected MDCK cells surface by immunofluorescence assay using rabbit's immunized antiserum. So, according to the sequence alignment based on the mentioned isolate and the result of immunoassay reaction, it seems recombinant vaccine based on A/chicken/Iran/101/1998(H9N2) M2 protein isolate might cover majority of influenza A virus strains specially H5 and H9 circulating in Iran and neighbor regions significantly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19809890     DOI: 10.1007/s11033-009-9851-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  18 in total

1.  Dissociation of influenza virus hemagglutinin and neuraminidase eliminates their intravirionic antigenic competition.

Authors:  B E Johansson; E D Kilbourne
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

2.  Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins.

Authors:  R A Lamb; C J Lai; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

3.  Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene.

Authors:  K Okuda; A Ihata; S Watabe; E Okada; T Yamakawa; K Hamajima; J Yang; N Ishii; M Nakazawa; K Okuda; K Ohnari; K Nakajima; K Q Xin
Journal:  Vaccine       Date:  2001-06-14       Impact factor: 3.641

4.  Protection against influenza virus challenge by topical application of influenza DNA vaccine.

Authors:  S Watabe; K Q Xin; A Ihata; L J Liu; A Honsho; I Aoki; K Hamajima; B Wahren; K Okuda
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

5.  Modified M2 proteins produce heterotypic immunity against influenza A virus.

Authors:  A M Frace; A I Klimov; T Rowe; R A Black; J M Katz
Journal:  Vaccine       Date:  1999-05-04       Impact factor: 3.641

6.  Immunologic response to influenza virus neuraminidase is influenced by prior experience with the associated viral hemagglutinin. II. Sequential infection of mice simulates human experience.

Authors:  B E Johansson; T M Moran; C A Bona; S W Popple; E D Kilbourne
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

7.  Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity.

Authors:  Andrea Jegerlehner; Nicole Schmitz; Tazio Storni; Martin F Bachmann
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

8.  Heterologous protection against influenza by injection of DNA encoding a viral protein.

Authors:  J B Ulmer; J J Donnelly; S E Parker; G H Rhodes; P L Felgner; V J Dwarki; S H Gromkowski; R R Deck; C M DeWitt; A Friedman
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

9.  Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein.

Authors:  V A Slepushkin; J M Katz; R A Black; W C Gamble; P A Rota; N J Cox
Journal:  Vaccine       Date:  1995       Impact factor: 3.641

10.  Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions.

Authors:  S L Zebedee; R A Lamb
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

View more
  6 in total

Review 1.  Influenza A viruses: why focusing on M2e-based universal vaccines.

Authors:  Seyyed Mahmoud Ebrahimi; Majid Tebianian
Journal:  Virus Genes       Date:  2010-11-17       Impact factor: 2.332

2.  Protection against Escherichia coli O157:H7 challenge by immunization of mice with purified Tir proteins.

Authors:  Hong-Ying Fan; Ling Wang; Jun Luo; Bei-Guo Long
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

3.  A highly sensitive immuno-PCR assay for detection of H5N1 avian influenza virus.

Authors:  Ming Jun Deng; Xi Zhi Xiao; Yan Ming Zhang; Xin Hai Wu; Lai Hua Zhu; Xue Qian Xin; Dong Lai Wu
Journal:  Mol Biol Rep       Date:  2010-09-22       Impact factor: 2.316

4.  Vaccination with virus-like particles containing H5 antigens from three H5N1 clades protects chickens from H5N1 and H5N8 influenza viruses.

Authors:  Darrell R Kapczynski; Terrence M Tumpey; Rachmat Hidajat; Aniko Zsak; Klaudia Chrzastek; Irina Tretyakova; Peter Pushko
Journal:  Vaccine       Date:  2016-02-08       Impact factor: 3.641

Review 5.  Development of a universal CTL-based vaccine for influenza.

Authors:  Diego Esteban Cargnelutti; María Victoria Sánchez; Nora Marta Mattion; Eduardo Alberto Scodeller
Journal:  Bioengineered       Date:  2013-01-21       Impact factor: 3.269

6.  Recombinant hemagglutinin of swine H1N1 influenza virus expression in the insect cells: Formulation in Montanide ISA71 adjuvant and the potency studies.

Authors:  Sara Zahmati; Morteza Taghizadeh; Setareh Haghighat; Reza Jalalirad; Mehdi Mahdavi
Journal:  Iran J Basic Med Sci       Date:  2021-11       Impact factor: 2.699

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.